Updates

July 6, 2026 The Manager The Manager BSE Limited National Stock Exchange of India Limited P. J Towers, Dalal Street, Fort "Exchange Plaza", C-1, Block G, Mumbai – 400 001 Bandra-Kurla Complex, Bandra (E), Scrip Code: 544009 Mumbai 400 051 Symbol: BLUEJET Sub: Qualified institutions placement of equity shares of face value of ₹ 2 each (the “Equity Shares”) by Blue Jet Healthcare Limited (the “Company”) under the provisions of Chapter VI of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the “SEBI ICDR Regulations”), and Sections 42 and 62 of the Companies Act, 2013 (including the rules made thereunder), as amended (the “Issue”). Dear Madam/ Sir, We wish to inform you that pursuant to the approval accorded by the board of directors of the Company (the “Board”), at its meeting held on May 25, 2026 and the shareholders of the Company, pursuant to the special resolution passed on June 17, 2026, the Investment and Finance Committee has, at its meeting held today i.e. July 6, 2026, inter alia, considered and approved the following resolutions: a. Approving and adopting the preliminary placement document dated July 6, 2026, together with the application form in connection with the Issue; b. Approving the floor price for the Issue, being ₹ 531.70 per Equity Share (“Floor Price”), based on the pricing formula as prescribed under the SEBI ICDR Regulations; and c. Authorizing the opening of the Issue today, i.e. July 6, 2026. We further wish to inform you that the Investment and Finance Committee has fixed the ‘relevant date’ for the purpose of the Issue, in terms of Regulation 171(b)(i) of the SEBI ICDR Regulations, as July 6, 2026, and accordingly the floor price in respect of the Issue has been determined, based on the pricing formula as prescribed under Regulation 176(1) of the SEBI ICDR Regulations, as ₹ 531.70 per Equity Share. Pursuant to Regulation 176(1) of the SEBI ICDR Regulations and in accordance with the approval of the Shareholders accorded through a special resolution passed at Extra-Ordinary General Meeting held on June 17, 2026, the Company may at its discretion offer a discount of not more than 5% on the floor price so calculated for the Issue. The Issue price will be determined by the Company in consultation with the book running lead managers appointed for the Issue. The meeting of the Investment and Finance Committee commenced at 7:00 pm and concluded at 7:30 pm. Copy of the preliminary placement document is also being made available on the website of the Company at www.bluejethealthcare.com. We request you to kindly take this on record, and the same be treated as compliance under Regulation 30 and other applicable regulations of the Securities and Exchange Board of India (Listing Obligations Disclosure Requirements) Regulations, 2015, as amended. For Blue Jet Healthcare Limited Sweta Poddar Company Secretary and Compliance Officer Membership No: F12287